Please login to the form below

Not currently logged in
Email:
Password:

anti-infectives

This page shows the latest anti-infectives news and features for those working in and with pharma, biotech and healthcare.

Daily Brief: Novartis exits anti-infectives drive, Hancock takes over from Hunt and Trump attacks 'soft Brexit' plan

Daily Brief: Novartis exits anti-infectives drive, Hancock takes over from Hunt and Trump attacks 'soft Brexit' plan

Daily Brief: Novartis exits anti-infectives drive, Hancock takes over from Hunt and Trump attacks 'soft Brexit' plan. ... Novartis has become the latest big pharma company to exit anti-infectives research, dealing a blow to efforts to generate new

Latest news

  • Evotec says Sanofi deal makes it anti-infectives powerhouse Evotec says Sanofi deal makes it anti-infectives powerhouse

    Evotec says Sanofi deal makes it anti-infectives powerhouse. It’s taken more than three months to work through the detail, but Sanofi has now signed a deal to transfer its ... It’s been reported that includes five-year employment contracts. The aim

  • Sanofi taps Evotec for new anti-infectives drive Sanofi taps Evotec for new anti-infectives drive

    the progress of novel anti-infectives on Evotec’s platform will be a key success factor”. ... Research in the field of anti-infectives is an area where building critical mass through partnering is particularly important.”.

  • Basilea bags $72m upfront from Pfizer for antifungal license Basilea bags $72m upfront from Pfizer for antifungal license

    Pfizer is a major player in anti-infectives with products such as antifungal Vfend (voriconazole), antibiotic Zyvox (linezolid) and its vaccines business, and the US drugmaker said its "well established global ... Basilea's chief executive Ronald Scott

  • Dr Reddy's brings its generics portfolio to France Dr Reddy's brings its generics portfolio to France

    Dr Reddy's brings its generics portfolio to France. Continues the European roll-out of its oncology and anti-infective products. ... The firm will introduce oncology and anti-infective generic products in the French hospital market, following their

  • Merck says drug for CMV in transplant patients hits targets Merck says drug for CMV in transplant patients hits targets

    AiCuris - which was formed as a spin-out from Bayer's anti-infectives unit in 2006 - pocketed an upfront payment of 110m and - with milestone payments - could get up to

More from news
Approximately 3 fully matching, plus 56 partially matching documents found.

Latest Intelligence

  • 30 women leaders in UK healthcare (part 3) 30 women leaders in UK healthcare (part 3)

    An immunologist with over two decades’experience in anti-infectives research and drug development, Deborah set up Novabiotics to discover and develop the next generation of treatments.

  • Deal Watch May 2016 Deal Watch May 2016

    Not only but also…. To close this month a recent report from the UK government expresses concerns about the lack of investment in anti-infectives R&D.

  • Another lost decade for research? Another lost decade for research?

    use but new classes of antibiotics - as well as non-antibiotic approaches such as other anti-infective treatments. ... Over the past 10 years the number of patent families filed in the antibiotics and anti-infectives field has remained stable, with

  • Pharma deals in June 2015 Pharma deals in June 2015

    The month of June saw a mixture of deals covering a wide range of therapeutic areas, including aesthetic medicine, CNS, diabetes, respiratory, vaccines and anti-infectives, oncology and autoimmune diseases. ... The consequences of acquisitions. One of

  • Pharma deals in February 2015 Pharma deals in February 2015

    Hospira's broad generic sterile injectables business covers acute care and oncology which compliments Pfizer's branded sterile injectables covering anti-infectives, anti-inflammatories and cytotoxics.

More from intelligence
Approximately 0 fully matching, plus 11 partially matching documents found.

Latest appointments

  • Damien McDevitt moves from GSK to Acadia Pharmaceuticals Damien McDevitt moves from GSK to Acadia Pharmaceuticals

    Prior to that, McDevitt held positions with increasing responsibility within worldwide business development at GSK Ventures and Anti-Infectives Discovery.

  • Nabriva Therapeutics appoints new chief commercial officer Nabriva Therapeutics appoints new chief commercial officer

    Lavino joins the Austrian clinical-stage biopharma firm from Merck &Co (MSD), bringing nearly two decades of pharmaceutical sales and marketing experience with expertise in anti-infective medications. ... Prior to serving MSD as its acting vice president,

  • Cidara Therapeutics makes senior appointments Cidara Therapeutics makes senior appointments

    Prior to BMS, Daruwala spent 18 years at Merck in a range of US and global commercial leadership roles in areas including anti-inflammatory products, business development and sales management. ... Cidara focuses on the discovery, development and

  • Xellia forms scientific advisory board Xellia forms scientific advisory board

    Xellia forms scientific advisory board. Will further progress on innovative anti-infectives. ... Xellia Pharmaceuticals, who have a focus on anti-infective treatments, has announced the formation of a new scientific advisory board.

  • Melinta names chief medical officer Melinta names chief medical officer

    She has prior experience in developing anti-infectives, including Cubicin (daptomycin) during her time at Novartis, where she served as VP and global programme head for the company's immunology and ... At Pharmacia, she worked on the anti-infective Zyvox

More from appointments
Approximately 0 fully matching, plus 14 partially matching documents found.

Latest from PMHub

  • SENIOR PHARMA MARKETER JOINS CELLO HEALTH CONSULTING

    He joined the company as Director of Early Phase Commercial Development, before heading up Astellas’ European marketing team for Anti-Infectives.

  • Hayward Medical Communications

    Allergic Disorders. Anaesthetics. Anti-infectives. Cancer/oncology. Cardiovascular. Central nervous system (CNS). Contraception.

  • SEVEN STONES

    Branding. Digital and tech solutions. Exercise co-prescription. Workplace wellbeing. Experience. Anti-infectives, cardiovascular, contrast media, dermatology, diabetes, diagnostics, gastroenterology, gene therapy, health and fitness, hepatology,

More from PMHub
Approximately 0 fully matching, plus 3 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Apex.co.uk Conferences, Events and Exhibition Stands

Apex.co.uk is one of the UK’s leading event and exhibition agencies, specialising in healthcare. We understand your communication goals, whether...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics